Hepatic lineage differentiation

Hepatic lineage differentiation" refers to the process by which pluripotent stem cells or hepatic progenitor cells are specified into the major cell types of the liver, primarily hepatocytes and cholangiocytes[1][3][5]. This process is controlled by a network of transcription factors—including FOXA1/2, GATA4/6, HHEX, HNF1A/1B—and signaling pathways such as Wnt, Notch, and FGF, among others[1][4][5]. The term is used widely in developmental biology and regenerative medicine to describe both the natural progression of liver formation during embryogenesis and the laboratory differentiation of stem cells into liver cell types for research or therapeutic purposes. "Hepatic lineage differentiation" is not a protein, receptor, enzyme, or other typical drug target, but rather a multicellular, multi-step developmental process[1][3][5].

Other names

hepatic differentiationliver lineage differentiationhepatic cell lineage specification